{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:14:08Z","timestamp":1746677648858,"version":"3.40.5"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We cover intensive care unit\u2013acquired neuromuscular disorders associated with coronavirus disease 2019. Outcomes may be worse than expected in these patients, and there is some evidence that coronavirus disease 2019 causes myopathy directly. Corticosteroid regimens in Duchenne muscular dystrophy are addressed including outcomes in pulmonary and cardiac function. A recent article notes a continued diagnostic delay in Duchenne muscular dystrophy. An interesting report of a Canary Islands cohort of patients with oculopharyngeal muscular dystrophy is discussed. Features and clinical pearls related to a series of patients with limb-girdle muscle dystrophy R12 (anoctaminopathy) and a misdiagnosis of idiopathic inflammatory myopathy are provided. The last section on autoimmune myopathy includes articles on clinical and pathologic features associated with myositis-specific antibodies and dermatomyositis, the epidemiology of immune-mediated necrotizing myopathies (IMNMs) in Olmsted County, Minnesota, and features of a German cohort of hydroxy-3-methylglutaryl coenzyme A reductase\u2013associated IMNM. A recent article proposes the benefit of early intravenous immunoglobulin use for adults with IMNM. We also highlight a report of 2 unusual cases of antisignal recognition particle myopathy presenting with asymmetric distal weakness.<\/jats:p>","DOI":"10.1097\/cnd.0000000000000428","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T12:02:07Z","timestamp":1661428927000},"page":"38-48","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["What Is in the Myopathy Literature?"],"prefix":"10.1097","volume":"24","author":[{"given":"Tawfiq","family":"Al-Lahham","sequence":"first","affiliation":[{"name":"Neurology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lacomis","sequence":"additional","affiliation":[{"name":"Neurology and"},{"name":"Pathology (Neuropathology), University of Pittsburgh School of Medicine, Pittsburgh, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250507","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1474-4422(11)70178-8","article-title":"Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis","volume":"10","author":"Latronico","year":"2011","journal-title":"Lancet Neurol."},{"key":"R2-20250507","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/mus.23615","article-title":"Electrophysiology of neuromuscular disorders in critical illness","volume":"47","author":"Lacomis","year":"2013","journal-title":"Muscle Nerve."},{"key":"R3-20250507","doi-asserted-by":"crossref","first-page":"jrm00257","DOI":"10.2340\/jrm.v53.1139","article-title":"Critical illness polyneuropathy and functional outcome in subjects with covid-19: report on four patients and a scoping review of the literature","volume":"54","author":"Intiso","year":"2022","journal-title":"J Rehabil Med."},{"key":"R4-20250507","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12883-022-02570-z","article-title":"Recovery and long-term functional outcome in people with critical illness polyneuropathy and myopathy: a scoping review","volume":"22","author":"Intiso","year":"2022","journal-title":"BMC Neurol."},{"key":"R5-20250507","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ana.26318","article-title":"Covid-19 associated critical illness myopathy with direct viral effects","volume":"91","author":"Dodig","year":"2022","journal-title":"Ann Neurol."},{"key":"R6-20250507","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.14336\/AD.2020.1014","article-title":"COVID-19 and acute sarcopenia","volume":"11","author":"Welch","year":"2020","journal-title":"Aging Dis."},{"key":"R7-20250507","doi-asserted-by":"crossref","first-page":"801133","DOI":"10.3389\/fendo.2022.801133","article-title":"Evaluation of muscle mass and stiffness with limb ultrasound in covid-19 survivors","volume":"13","author":"Damanti","year":"2022","journal-title":"Front Endocrinol."},{"key":"R8-20250507","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clinimag.2019.06.006","article-title":"Ultrasound shear wave elastography in assessment of skeletal muscle stiffness in senior volunteers","volume":"58","author":"Phan","year":"2019","journal-title":"Clin Imaging."},{"key":"R9-20250507","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jpeds.2009.02.007","article-title":"Delayed diagnosis in Duchenne muscular dystrophy: data from the muscular dystrophy surveillance, tracking and research network (MD STARnet)","volume":"155","author":"Ciafoloni","year":"2009","journal-title":"J Pediatr."},{"key":"R10-20250507","first-page":"1","article-title":"Time to diagnosis of Duchenne muscular dystrophy remains unchanged. Findings from the muscular dystrophy surveillance, tracking, and research network, 2000-2015","author":"Thomas","year":"2022","journal-title":"Muscle Nerve."},{"key":"R11-20250507","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.2022.4315","article-title":"Effect of different corticosteroid dosing regimens on clinical outcomes in boys with Duchenne muscular dystrophy. A randomized clinical trial","volume":"327","author":"Guglieri","year":"2022","journal-title":"JAMA"},{"key":"R12-20250507","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mus.27490","article-title":"Evaluation of effects of continued corticosteroid treatment on cardiac and pulmonary function in non-ambulatory males with Duchenne muscular dystrophy from MD STARnet","volume":"66","author":"Butterfield","year":"2022","journal-title":"Muscle Nerve."},{"key":"R13-20250507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.27548","article-title":"Corticosteroids after loss of ambulation in Duchenne muscular dystrophy: a dilemma for the ages","volume":"66","author":"Paul","year":"2022","journal-title":"Muscle Nerve."},{"key":"R14-20250507","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/ene.15252","article-title":"Clinical and genetic features of a large homogeneous cohort of oculopharyngeal muscular dystrophy patients from the Canary Islands","volume":"29","author":"Alonso-Perez","year":"2022","journal-title":"Eur J Neurol."},{"key":"R15-20250507","first-page":"575","article-title":"Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy","volume":"90","author":"Alonso-Perez","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"R16-20250507","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/rheumatology\/keab553","article-title":"Limb girdle muscular dystrophy R12 (LGMD 2L, anoctaminopathy) mimicking idiopathic inflammatory myopathy: key points to prevent misdiagnosis","volume":"61","author":"Marago","year":"2022","journal-title":"Rheumatology"},{"key":"R17-20250507","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mus.27419","article-title":"Muscle biopsy and MRI findings in ANO5-related myopathy","volume":"64","author":"Holm-Yildiz","year":"2021","journal-title":"Muscle Nerve."},{"key":"R18-20250507","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1212\/WNL.0000000000013176","article-title":"Dermatomyositis: muscle pathology according to antibody subtypes","volume":"98","author":"Tanboon","year":"2022","journal-title":"Neurology"},{"key":"R19-20250507","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/rheumatology\/keab518","article-title":"Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash","volume":"61","author":"Ichimura","year":"2022","journal-title":"Rheumatology (Oxford)."},{"key":"R20-20250507","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1573397114666180406101850","article-title":"Immune mediated necrotizing myopathy: where do we stand?","volume":"15","author":"Mohammed","year":"2019","journal-title":"Curr Rheumatol Rev."},{"key":"R21-20250507","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat Rev Rheumatol."},{"key":"R22-20250507","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mus.27504","article-title":"Incidence and prevalence of immune-mediated necrotizing myopathy in adults in Olmsted County, Minnesota","volume":"65","author":"Shelly","year":"2022","journal-title":"Muscle Nerve."},{"key":"R23-20250507","doi-asserted-by":"crossref","first-page":"320","DOI":"10.55563\/clinexprheumatol\/2ao5ze","article-title":"Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data","volume":"40","author":"Rademacher","year":"2022","journal-title":"Clin Exp Rheumatol."},{"key":"R24-20250507","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nmd.2021.11.010","article-title":"Unusual cases of Anti-SRP necrotizing myopathy with predominant distal leg weakness and atrophy","volume":"32","author":"Moshe-Lilie","year":"2022","journal-title":"Neuromuscul Disord."},{"issue":"2","key":"R25-20250507","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1097\/RHU.0000000000001786","article-title":"Intravenous immunoglobulin in necrotizing autoimmune myopathy","volume":"28","author":"Kocoloski","year":"2022","journal-title":"J Clin Rheumatol."}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T21:03:29Z","timestamp":1746651809000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0000000000000428","relation":{},"ISSN":["1522-0443"],"issn-type":[{"type":"print","value":"1522-0443"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}